From climate-neutral industry and new mobility solutions to global health research: Germany’s innovation clusters are developing the ideas that will shape our society tomorrow. At re:publica 2026, the cluster and campus initiatives of the Federal Ministry of Research, Technology and Space (BMFTR) will, for the first time, jointly showcase their success stories. The PROXIDRUGS Cluster, based at Goethe University Frankfurt, is developing innovative drugs that can selectively degrade...

PROXIDRUGS scientist Xinlai Cheng and Cluster Speaker Ivan Đikić from Goethe University Frankfurt have received one of the prizes of the Innovation Award of the German BioRegions 2026 for their project “SpliceTACs: First-in-class spliceosome-targeting degraders.” The project had previously been selected as one of six finalists in this year’s competition and was presented on April 21, 2026, during the German Biotechnology Days in Leipzig to a high-level audience of investors, company...

The Clusters4Future PROXIDRUGS, curATime, and CNATM jointly invited participants to the conference “Therapeutic Frontiers in Medicine: Mechanisms and Modalities 2026” in Bad Homburg. The event was aimed at researchers, clinicians, and professionals from industry, placing a strong focus on current developments in translational medicine. Over a period of four days, more than 200 participants engaged in intensive exchange, including around 40 speakers. Discussions covered new therapeutic...